Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

Quintiles logo

The New Health is data driven. Biopharma is swimming in oceans of data, and it’s still growing exponentially. Quintiles is introducing a singular way to aggregate, harmonize and gain insights from your data. Quintiles Infosario™ is a new platform that allows you to view data from multiple sources—sites, labs, ECG, finance, HR and more—all in one place. So you can make better decisions, faster.

Learn how Quintiles can help you move from information to insights—and from insights to outcomes. Watch From Information to Insight at quintiles.com/newhealth

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- CI Precision
- Cisbio Bioassays
- Colder Products Company
- DCA Design International
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau GmbH
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Watson-Marlow Pumps Group

Add your company

Conferences, events & exhibitions

High Content Analysis 2012
10 - 13 January 2012, San Francisco, CA, USA

IFPAC 2012
22 - 25 January 2012, Baltimore, USA

SLAS 2012
4 - 8 February 2012, San Diego, CA, USA

Drug Discovery for Neurodegeneration
12 - 14 February 2012, New York, USA

4th International Conference on Drug Discovery and Therapy
12 - 15 February 2012, Dubai, UAE

9th Annual PAT and Quality by Design
20 - 22 February 2012, London, UK

7th Annual Biomarkers Congress
22 - 23 February 2012, Manchester, UK

BIA Research & Development Conference
28 February 2012, London, UK

GDDIF 2012
7 - 8 March 2012, Budapest, Hungary

Amgen and Watson announce collaboration to develop and commercialise oncology biosimilars

Oncology biosimilars research

Amgen and Watson Pharmaceuticals, Inc. have announced that they will collaborate to develop and commercialise, on a worldwide basis, several oncology antibody biosimilar medicines. This collaboration reflects the shared belief that the development and commercialisation of biosimilar products will not follow a pure brand or generic model, and will require significant expertise, infrastructure, and investment to ensure safe, reliably supplied therapies for patients.

Read the full story >>

More pharmaceutical & life science news

Bayer’s Xarelto® approved in the EU for the prevention of stroke in patients
The only new oral anticoagulant approved in three indications across all 27 EU member states...

Alkermes initiates phase 3 clinical study of ALKS 9070 for treatment of schizophrenia
ALKS 9070 is designed to offer once-monthly version of Aripiprazole...

AstraZeneca updates on olaparib and TC-5214 development programmes
With associated impairment charges, company confirms full year financial target...

Roche’s personalised medicine Zelboraf receives positive opinion from European authority
For the treatment of people with BRAF mutation-positive metastatic melanoma...

Pfizer reports positive results from Phase 3 trial Of Lyrica (pregabaline)
Patients with Restless Legs Syndrome (RLS) show significant benefit...

GSK extends pneumococcal vaccine agreement with GAVI Alliance
Move aims to protect millions more children in the world's poorest countries from pneumococcal disease...

Sharer to step down as chairman and chief executive officer of Amgen
Kevin W. Sharer has announced his plan to retire from the Company at the end of 2012...

Simcere and Bristol-Myers Squibb enter innovative partnership to develop cardiovascular compound
The companies have expanded the strategic partnership formed last year...

New Intrauterine System for long-term contraception submitted for marketing authorization both in the EU and the U.S.
Once approved, the new low dose IUS will offer contraception for up to three years...

Final results from largest phase 3 open-label study assessing Nplate®
Additional key Nplate (Romiplostim) data also presented at American Society of Hematology annual meeting...

Merck announces initiation of clinical development collaboration with Roche
New clinical trial will evaluate an investigational therapeutic regimen with VICTRELIS™ (boceprevir)...

Featured supplier news

Syrris chemical reactors – good under pressure
Syrris, offers a range of reactors designed specifically for applications requiring elevated pressures...

B&W Tek announces PolymerIQTM for quantification of polymers in partnership with Gnosys Global Ltd
B&W Tek, Inc., announced its newest strategic partnership with Gnosys Global, Ltd...

Syrris releases new batch chemistry reactors catalogue
Syrris is pleased to announce the release of its new batch chemistry reactors catalogue...

Tecan launches Infinite® M1000 PRO with AlphaScreen® and AlphaLISA® technology
Infinite M1000 PRO is Tecan’s latest generation high-end multimode microplate reader...

Featured report - act now to save 225 dollars

Biotechnology: Global Industry Guide

Price: 1270.75 dollars (VALID TO 23/12/2011, Promotion Code: EOY11, normal price 1495 dollars)

Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Find out more & order >>